Growth Metrics

Biogen (BIIB) Work In Process (2016 - 2018)

Biogen has reported Work In Process over the past 9 years, most recently at $606.7 million for Q4 2018.

  • Quarterly results put Work In Process at $606.7 million for Q4 2018, changed 0.17% from a year ago — trailing twelve months through Dec 2018 was $606.7 million (changed 0.17% YoY), and the annual figure for FY2018 was $606.7 million, changed 0.17%.
  • Work In Process for Q4 2018 was $606.7 million at Biogen, roughly flat from $605.7 million in the prior quarter.
  • Over the last five years, Work In Process for BIIB hit a ceiling of $698.7 million in Q4 2016 and a floor of $511.5 million in Q4 2014.
  • Median Work In Process over the past 5 years was $605.7 million (2017), compared with a mean of $600.0 million.
  • Biggest five-year swings in Work In Process: rose 20.97% in 2016 and later dropped 13.31% in 2017.
  • Biogen's Work In Process stood at $511.5 million in 2014, then rose by 12.92% to $577.6 million in 2015, then rose by 20.97% to $698.7 million in 2016, then dropped by 13.31% to $605.7 million in 2017, then increased by 0.17% to $606.7 million in 2018.
  • The last three reported values for Work In Process were $606.7 million (Q4 2018), $605.7 million (Q4 2017), and $698.7 million (Q4 2016) per Business Quant data.